76
Views
6
CrossRef citations to date
0
Altmetric
Original Research

The drug efficacy and adverse reactions in a mouse model of oral squamous cell carcinoma treated with oxaliplatin at different time points during a day

, , , &
Pages 511-517 | Published online: 20 Jun 2013

References

  • Kademani D Bell RB Schmidt BL Oral and maxillofacial surgeons treating oral cancer: a preliminary report from the American Association of Oral and Maxillofacial Surgeons Task Force on Oral Cancer J Oral Maxillofac Surg 2008 66 10 2151 2157 18848117
  • Kademani D Bell RB Bagheri S Prognostic factors in intraoral squamous cell carcinoma: the influence of histologic grade J Oral Maxillofac Surg 2005 63 11 1599 1605 16243176
  • Eismann EA Lush E Sephton SE Circadian effects in cancer-relevant psychoneuroendocrine and immune pathways Psychoneuroendocrinology 2010 35 7 963 976 20097011
  • Huang XL Fu CJ Bu RF Role of circadian clocks in the development and therapeutics of cancer J Int Med Res 2011 39 6 2061 2066 22289520
  • Lévi F Okyar A Dulong S Innominato PF Clairambault J Circadian timing in cancer treatments Annu Rev Pharmacol Toxicol 2010 50 377 421 20055686
  • Lévi F Chronotherapeutics: the relevance of timing in cancer therapy Cancer Causes Control 2006 17 4 611 621 16596317
  • Levi F Zidani R Misset JL Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer. International Organization for Cancer Chronotherapy Lancet 1997 350 9079 681 686 9291901
  • Lemmer B Chronobiology, drug-delivery, and chronotherapeutics Adv Drug Deliv Rev 2007 59 9–10 825 827 17825947
  • Santini D Vincenzi B Schiavon G Chronomodulated administration of oxaliplatin plus capecitabine (XELOX) as first line chemotherapy in advanced colorectal cancer patients: phase II study Cancer Chemother Pharmacol 2007 59 5 613 620 16944151
  • Garufi C Brienza S Pugliese P Overcoming resistance to chronomodulated 5-fluorouracil and folinic acid by the addition of chronomodulated oxaliplatin in advanced colorectal cancer patients Anticancer Drugs 2000 11 6 495 501 11001391
  • Davidson AJ Straume M Block GD Menaker M Daily timed meals dissociate circadian rhythms in hepatoma and healthy host liver Int J Cancer 2006 118 7 1623 1627 16231323
  • Zhao N Tang H Yang K Chen D Circadian rhythm characteristics of oral squamous cell carcinoma growth in an orthotopic xenograft model Onco Targets Ther 2013 6 41 46 23378773
  • Manoharan S Baskar AA Manivasagam T Subramanian P Circadian rhythmicity of plasma lipid peroxidation and antioxidants in oral squamous cell carcinoma Singapore Med J 2005 46 4 184 188 15800725
  • Kelland L The resurgence of platinum-based cancer chemotherapy Nat Rev Cancer 2007 7 8 573 584 17625587
  • Singletary J Wood PA Du-Quiton J Imaging multidimensional therapeutically relevant circadian relationships Int J Biomed Imaging 2009 2009 231539 19688113
  • Wood PA Du-Quiton J You S Hrushesky WJ Circadian clock coordinates cancer cell cycle progression, thymidylate synthase, and 5-fluorouracil therapeutic index Mol Cancer Ther 2006 5 8 2023 2033 16928823
  • Kelland L Broadening the clinical use of platinum drug-based chemotherapy with new analogues. Satraplatin and picoplatin Expert Opin Investig Drugs 2007 16 7 1009 1021
  • Blumenthal RD Osorio L Ochakovskaya R Ying Z Goldenberg DM Regulation of tumour drug delivery by blood flow chronobiology Eur J Cancer 2000 36 14 1876 1884 10974637
  • Hori K Zhang QH Li HC Saito S Sato Y Timing of cancer chemotherapy based on circadian variations in tumor tissue blood flow Int J Cancer 1996 65 3 360 364 8575858
  • Lévi F Focan C Karaboué A Implications of circadian clocks for the rhythmic delivery of cancer therapeutics Adv Drug Deliv Rev 2007 59 9–10 1015 1035 17692427
  • Zeng ZL Sun J Guo L Circadian rhythm in dihydropyrimidine dehydrogenase activity and reduced glutathione content in peripheral blood of nasopharyngeal carcinoma patients Chronobiol Int 2005 22 4 741 754 16147904
  • Granda TG Lévi F Tumor-based rhythms of anticancer efficacy in experimental models Chronobiol Int 2002 19 1 21 24 11962677
  • Vincenzi B Santini D La Cesa A Tonini G Cancer chronotherapy: principles, applications, and perspectives Cancer 2003 98 4 881 883 12910534
  • Innominato PF Lévi FA Bjarnason GA Chronotherapy and the molecular clock: clinical implications in oncology Adv Drug Deliv Rev 2010 62 9–10 979 1001 20600409